Hologic, Inc. HOLX announced an extension of its LOCalizer radiofrequency identification (“RFID”) tag’s CE Mark. Under the extended approval, the tag can now be implanted more than 30 days prior to ...
TUCSON, Ariz.--(BUSINESS WIRE)--Faxitron, a 50-year leader in advancing technology for breast health today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to ...
MARLBOROUGH, Mass.-- (BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced the granting of a CE Mark to the LOCalizer™ wireless radio frequency identification (RFID) breast lesion localization ...
Tucson, AZ – June 13, 2018 – Faxitron, a global leader in best-in-class digital specimen imaging systems for breast cancer intervention and life science research, today announced that Carroll Hospital ...
Hologic, Inc. HOLX announced an extension of its LOCalizer radiofrequency identification (“RFID”) tag’s CE Mark. Under the extended approval, the tag can now be implanted more than 30 days prior to ...
The LOCalizer tag is designed to replace the traditional wire-guided localization method, helping to provide increased comfort and convenience for patients and their healthcare teams. The tag can be ...
Latest addition to growing portfolio of breast and skeletal health innovations to be featured at ECR 2019 Hologic, Inc. (Nasdaq: HOLX) today announced the granting of a CE Mark to the LOCalizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback